全球快速药物筛选市场 – 行业趋势及 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球快速药物筛选市场 – 行业趋势及 2029 年预测

  • Healthcare
  • Upcoming Report
  • Oct 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Rapid Drug Screen Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2022 –2029
Diagram Market Size (Base Year)
USD 8.30 Million
Diagram Market Size (Forecast Year)
USD 12.26 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Abbott
  • Thermo Fisher Scientific
  • Medtronic
  • BD
  • Roche

全球快速药物筛查市场,按组件(带温度条的透明塑料收集杯、开槽盖、标准盖、测试卡)、培训(基于网络的培训、CD-ROM 培训、现场培训)、药物类型(安非他明、甲基安非他明、大麻代谢物、可卡因、阿片类药物、苯环利定、巴比妥类药物、苯二氮卓类药物、美沙酮、丙氧芬、羟可酮/羟吗啡酮、氢可酮/氢吗啡酮、其他)、最终用户(工作场所、刑事司法系统和执法机构、药物治疗中心、疼痛管理中心、学校和学院、医院、个人用户、药物检测实验室)划分 - 行业趋势和预测到 2029 年。

快速药物筛选市场

快速药物筛选市场分析和规模

根据《2021 年世界毒品报告》,2019 年,全球约有 2.75 亿 15-64 岁人群(即该年龄段每 18 人中就有 1 人)在前一年至少吸过一次毒。同年,吸毒导致近 50 万人死亡,而药物使用障碍导致 1800 万年健康寿命受损,主要原因是阿片类药物。酒精消费量也出现了类似的增长,其后果是酒驾发生率上升。

Data Bridge Market Research 分析,快速药物筛选市场在 2021 年为 830 万美元,到 2029 年将飙升至 122.6 亿美元,预计在 2022 年至 2029 年的预测期内复合年增长率为 5%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

快速药物筛选市场范围和细分      

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制为 2014 - 2019)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

组件(带温度条的透明塑料收集杯、开槽盖、标准盖、测试卡)、培训(基于 Web 的培训、CD-ROM 培训、现场培训)、药物类型(安非他明、甲基安非他明、大麻代谢物、可卡因、阿片类药物、苯环利定、巴比妥类药物、苯二氮卓类药物、美沙酮、丙氧芬、羟可酮/羟吗啡酮、氢可酮/氢吗啡酮、其他)、最终用户(工作场所、刑事司法系统和执法机构、药物治疗中心、疼痛管理中心、学校和学院、医院、个人用户、药物检测实验室)

覆盖国家

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Abbott (U.S.), Thermo fisher Scientific Inc. (U.S.), Medtronic (Ireland), BD (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Drägerwerk AG & Co. KGaA (Germany), Laboratory Corporation of America Holdings (U.S.), Quest Diagnostics Incorporated (U.S.), Alfa Scientific Designs, Inc. (U.S.), Lifeloc Technologies Inc (U.S.), OraSure Technologies, Inc. (U.S.), Omega Laboratories, Inc. (U.S.)

Market Opportunities

  • Increasing applications from developing economies
  •  Emergence of advanced technologies

Market Definition

Drug screening is a technique for detecting illegal substances in saliva, sperm, and other biological samples. During this process, potential drugs are identified and engineered to proceed to clinical trials until a candidate product is selected. This includes scanning large chemical collections for a specific biological operation in high-throughput screening assays.  

Global Rapid Drug Screen Market Dynamics

Drivers

  • Government Initiatives

The US government is implementing a number of initiatives to monitor symptoms and determine whether a person is abusing drugs. For instance, the Patients and Communities Act of 2018 was a law passed by the country to combat drug abuse. Thus, rising drug and alcohol abuse, as well as strict regulations to detect intoxication in the body, are expected to propel the market growth during the forecast period.

  • Drug screen use in hospitals

The accumulating evidence of increasing prevalence of drug misuse in the general population and on hospital wards, the need to detect drug misuse in order to reach an accurate diagnosis and the availability of effective interventions to help in-patients who are misusing substances and to treat presenting complications are the three reasons for screening for drug misuse in hospital settings. These are the certain reasons which propel the growth of market.

Furthermore, increasing drug screen usage for the prevalence of results, the ability to administer the entire test right on site, rising demand for cost effective tests and the prevalence of funds for the improvement of the healthcare sector will likely boost the growth of the rapid drug screen market during the forecast period of 2022-2029.

Opportunities

  • Increasing applications from developing economies

随着口腔液体检测和先进技术的出现,发展中经济体的应用不断增加,这将在预测期内为快速药物筛选市场的增长带来充足的机会。

限制/挑战

  • 缺乏医疗基础设施

医疗基础设施缺乏改善以及检测能力有限将阻碍市场的增长。然而,低效的存储程序、高成本和缺乏熟练的人员是制约该市场增长的一些因素。

本快速药物筛选市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入来源、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新等方面的机会。如需了解有关快速药物筛选市场的更多信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。

最新动态

  • 2021 年 8 月,Quest Diagnostics 与南卡罗来纳州 Select Health 签署了一项协议,以扩大 Select Health 的实验室网络,供 Medicaid 和 Medicare-Medicaid 双重合格参保者使用,并改善会员获取诊断信息服务的渠道
  • 2020 年 5 月,Psychemedics 推出了一项电子烟测试,可以检测通过任何方式(包括电子烟​​或吸烟)摄入大麻、CBD 和尼古丁药物的情况
  • 2020 年 9 月,Labcorp 和 Infirmary Health 宣布了一项多年期合作协议,为整个墨西哥湾东部沿岸地区的患者和医疗服务提供者提供实验室服务

全球快速药物筛选市场范围

快速药物筛选市场根据成分、培训、药物类型和最终用户进行细分。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

成分

  • 带温度条的透明塑料收集杯
  • 开槽盖
  • 标准盖
  • 测试卡

 训练

  • 基于网络的培训
  • 光盘培训
  • 现场培训

 药物类型

  • 安非他明
  • 甲基苯丙胺
  • 大麻代谢物
  • 可卡因
  • 鸦片类药物
  • 苯环利定
  • 巴比妥类药物
  • 苯二氮卓类
  • 美沙酮
  • 丙氧芬
  • 羟可酮/羟吗啡酮
  • 氢可酮/氢吗啡酮
  • 其他的

 最终用户

  • 工作场所
  • 刑事司法系统和执法机构
  • 药物治疗中心
  • 疼痛管理中心
  • 学校和学院
  • 医院
  • 个人用户
  • 药物检测实验室

 快速药物筛选市场区域分析/见解

对快速药物筛查市场进行了分析,并按国家、组成部分、培训、药物类型和最终用户提供了市场规模见解和趋势。

快速药物筛查市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于存在支持药物筛查的法律以及用于遏制药物滥用的资金,北美在快速药物筛查市场占据主导地位。

由于药物筛查意识的不断提高,预计亚太地区将在 2022 年至 2029 年的预测期内实现最高增长率。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和快速药物筛选市场份额分析

快速药物筛选市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对快速药物筛选市场的关注有关。

快速药物筛选市场的一些主要参与者包括:

  • 雅培(美国)
  • 赛默飞世尔科技公司(美国)
  • 美敦力(爱尔兰)
  • BD(美国)
  • F. Hoffmann-La Roche Ltd.(瑞士)
  • Drägerwerk AG & Co. KGaA(德国)
  • 美国实验室控股公司(美国)
  • Quest Diagnostics Incorporated(美国)
  • Alfa Scientific Designs, Inc.(美国)
  • Lifeloc Technologies Inc(美国)
  • OraSure Technologies, Inc.(美国)
  • Omega Laboratories, Inc.(美国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on ,  By Component (Clear Plastic Collection Cup with Temperature Strip, Slotted Lid, Standard Lid, Test Card), Training (Web Based Training, CD-ROM Training, Onsite Training), Drug Type (Amphetamine, Methamphetamine, Marijuana Metabolite, Cocaine, Opiates, Phencyclidine, Barbiturates, Benzodiazepines, Methadone, Propoxyphene, Oxycodone/Oxymorphone, Hydrocodone/Hydromorphone, Others), End User (Workplace, Criminal Justice Systems and Law Enforcement Agencies, Drug Treatment Centers, Pain Management Centers, Schools and Colleges, Hospitals, Individual Users, Drug Testing Laboratories) – Industry Trends and Forecast to 2029. .
The Global Rapid Drug Screen Market size was valued at USD 8.30 USD Million in 2021.
The Global Rapid Drug Screen Market is projected to grow at a CAGR of 5% during the forecast period of 2022 to 2029.
The major players operating in the market include Abbott, Thermo Fisher Scientific , Medtronic, BD, Roche , Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics orporated, Alfa Scientific Designs , Lifeloc Technologies , OraSure Technologies , Omega Laboratories .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..